Filter
388
Text search:
antigen
Featured
Recommendations
42
New Publications
78
Language
Document type
No document type
175
Guidelines
86
Studies & Reports
52
Manuals
24
Fact sheets
20
Strategic & Response Plan
16
Training Material
8
Situation Updates
3
Brochures
2
Resource Platforms
1
Online Courses
1
Countries / Regions
India
18
Global
15
Nigeria
11
Germany
11
Africa
11
Western and Central Europe
9
Kenya
8
Tanzania
8
Sierra Leone
7
Ukraine
7
Philippines
6
Ethiopia
5
Rwanda
5
South Africa
5
Liberia
4
Congo, Democratic Republic of
4
Ghana
4
Uganda
4
Zimbabwe
3
Syria
3
Indonesia
3
Namibia
3
Brazil
3
Burkina Faso
2
Cameroon
2
Cambodia
2
Bangladesh
2
Malawi
2
Myanmar / Burma
2
East and Southern Africa
2
West and Central Africa
2
South–East Asia Region
2
Latin America and the Carribbean
2
Russia
2
USA
1
Saudi Arabia
1
Haiti
1
Somalia
1
Nepal
1
South Sudan
1
Papua New Guinea
1
Benin
1
North Macedonia
1
Colombia
1
Ecuador
1
Libya
1
Lesotho
1
Chile
1
Middle East and North Africa
1
Eastern Europe
1
Kazakhstan
1
Authors & Publishers
Publication Years
Category
Countries
122
Clinical Guidelines
58
Pharmacy & Technologies
24
Public Health
14
Women & Child Health
11
Key Resources
11
Capacity Building
1
Toolboxes
COVID-19
68
HIV
48
NTDs
46
TB
36
Rapid Response
20
Ebola & Marburg
14
Refugee
10
Conflict
7
Mental Health
7
2.0 Rapid Response
7
Caregiver
6
Zika
5
Pharmacy
5
Natural Hazards
4
Cholera
3
NCDs
3
Malaria
3
Polio
2
Planetary Health
2
AMR
1
Guidelines for Therapy and Management of Urothelial Urinary Bladder Cancer
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
The present DHR-ICMR guidelines comprehensively address the various concerns regarding the clinical assessment, treatment, and laboratory diagnosis of rickettsial diseases in India and the world. It is hoped that physicians, health care workers, the scientific community, the regulatory agencies, pub
...
An Action Framework and annexe to Immunization Agenda 2030 (Draft version)
27 January 2021
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method
...
Workplaces outside of healthcare facilities can be also settings for transmission of COVID-19. Outbreaks of COVID-19 has been reported in various types of workplaces and job categories.
All workers should be protected from acquiring COVID-19 because of their work. The prevention of COVID-19 in
...
In 2020, the COVID-19 pandemic impacted the world beyond imagination. To date, it has infected more than 135 million people, killed over 2.9 million people, and is projected to plunge up to 115 million people into extreme poverty.1 As countries have gone into lockdown, gender-based violence has incr
...
Pharmaceutical News
Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis
Consultation Documents
Lamivudine and tenofovir disoproxil fumarate tablets (lami
...
Revised and expanded version of the Guidelines
Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force
Working document from an informal consultation of experts. A Protocol for risk assessment at the field level. The purpose of document is to provide guidance on the methodology to be used for assessing, at field level, the yellow fever virus circulation in areas at risk, and is primarily intended fo
...
The 7th edition of the Orange Guide provides practical guidance to health workers on the front line of TB control. It includes sections on HIV, MDR-TB and a review of the recommended treatment regimens
Recommendations for Tuberculosis Screening Before Initiation of TNF-α-Inhibitor Treatment in Rheumatic Diseases
Diel R et al. Empfehlungen für das Tuberkulosescreening vor Gabe von TNF-α-Inhibitoren… Pneumologie 2009; 63: 329–334
